S&P 500   3,391.35 (+0.62%)
DOW   29,399.05 (+0.57%)
QQQ   237.19 (+1.05%)
AAPL   324.13 (+1.61%)
FB   217.47 (-0.15%)
MSFT   187.12 (-0.06%)
GOOGL   1,528.07 (+0.57%)
AMZN   2,180.64 (+1.16%)
CGC   21.73 (-0.96%)
NVDA   312.65 (+5.42%)
BABA   222.06 (+0.70%)
MU   59.51 (+3.05%)
GE   12.85 (+0.78%)
AMD   59.15 (+3.97%)
T   38.53 (+0.71%)
ACB   1.71 (+4.27%)
F   8.01 (-0.62%)
NFLX   387.68 (-0.03%)
BAC   34.82 (+1.58%)
DIS   141.56 (+1.74%)
GILD   66.99 (-0.03%)
S&P 500   3,391.35 (+0.62%)
DOW   29,399.05 (+0.57%)
QQQ   237.19 (+1.05%)
AAPL   324.13 (+1.61%)
FB   217.47 (-0.15%)
MSFT   187.12 (-0.06%)
GOOGL   1,528.07 (+0.57%)
AMZN   2,180.64 (+1.16%)
CGC   21.73 (-0.96%)
NVDA   312.65 (+5.42%)
BABA   222.06 (+0.70%)
MU   59.51 (+3.05%)
GE   12.85 (+0.78%)
AMD   59.15 (+3.97%)
T   38.53 (+0.71%)
ACB   1.71 (+4.27%)
F   8.01 (-0.62%)
NFLX   387.68 (-0.03%)
BAC   34.82 (+1.58%)
DIS   141.56 (+1.74%)
GILD   66.99 (-0.03%)
S&P 500   3,391.35 (+0.62%)
DOW   29,399.05 (+0.57%)
QQQ   237.19 (+1.05%)
AAPL   324.13 (+1.61%)
FB   217.47 (-0.15%)
MSFT   187.12 (-0.06%)
GOOGL   1,528.07 (+0.57%)
AMZN   2,180.64 (+1.16%)
CGC   21.73 (-0.96%)
NVDA   312.65 (+5.42%)
BABA   222.06 (+0.70%)
MU   59.51 (+3.05%)
GE   12.85 (+0.78%)
AMD   59.15 (+3.97%)
T   38.53 (+0.71%)
ACB   1.71 (+4.27%)
F   8.01 (-0.62%)
NFLX   387.68 (-0.03%)
BAC   34.82 (+1.58%)
DIS   141.56 (+1.74%)
GILD   66.99 (-0.03%)
S&P 500   3,391.35 (+0.62%)
DOW   29,399.05 (+0.57%)
QQQ   237.19 (+1.05%)
AAPL   324.13 (+1.61%)
FB   217.47 (-0.15%)
MSFT   187.12 (-0.06%)
GOOGL   1,528.07 (+0.57%)
AMZN   2,180.64 (+1.16%)
CGC   21.73 (-0.96%)
NVDA   312.65 (+5.42%)
BABA   222.06 (+0.70%)
MU   59.51 (+3.05%)
GE   12.85 (+0.78%)
AMD   59.15 (+3.97%)
T   38.53 (+0.71%)
ACB   1.71 (+4.27%)
F   8.01 (-0.62%)
NFLX   387.68 (-0.03%)
BAC   34.82 (+1.58%)
DIS   141.56 (+1.74%)
GILD   66.99 (-0.03%)
Log in

NYSE:MET - Metlife Stock Price, Forecast & News

$51.96
+0.14 (+0.27 %)
(As of 02/19/2020 12:29 PM ET)
Today's Range
$51.71
Now: $51.97
$52.16
50-Day Range
$49.69
MA: $51.55
$52.61
52-Week Range
$41.41
Now: $51.97
$53.28
Volume1.91 million shs
Average Volume4.93 million shs
Market Capitalization$47.79 billion
P/E Ratio8.59
Dividend Yield3.37%
Beta1.07
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. Read More…

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$5.11 per share
Book Value$72.18 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Employees48,000
Market Cap$47.79 billion
Next Earnings Date5/6/2020 (Estimated)
OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.


Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, January 7th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.44 per share on Friday, March 13th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.39%. The ex-dividend date is Monday, February 3rd. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife announced that its Board of Directors has approved a stock repurchase plan on Thursday, November 1st 2018, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 4.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) released its quarterly earnings results on Wednesday, February, 5th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.40 by $0.58. The financial services provider earned $18.15 billion during the quarter, compared to analysts' expectations of $16.82 billion. Metlife had a net margin of 8.39% and a return on equity of 9.14%. Metlife's revenue was up 17.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.35 earnings per share. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, May 6th 2020. View Earnings Estimates for Metlife.

What price target have analysts set for MET?

10 analysts have issued 12 month price objectives for Metlife's shares. Their forecasts range from $41.00 to $60.00. On average, they anticipate Metlife's share price to reach $52.67 in the next twelve months. This suggests a possible upside of 1.4% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. Acquisitions made by the company will diversify its business and aid inorganic growth. Its disciplined capital deployment is expected to drive long-term growth and create wealth for shareholders. However, its exposure to catastrophe loss remains a concern. Investment in efficiency programs will likely put pressure on margins. Also, the company's net investment income might continue to decline in 2019 due to lower interest rates, which will likely pressurize investment yields." (12/9/2019)
  • 2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)

Has Metlife been receiving favorable news coverage?

News stories about MET stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Metlife earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the financial services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Metlife.

Are investors shorting Metlife?

Metlife saw a increase in short interest in January. As of January 31st, there was short interest totalling 16,060,000 shares, an increase of 20.7% from the January 15th total of 13,310,000 shares. Based on an average trading volume of 4,970,000 shares, the days-to-cover ratio is currently 3.2 days. Approximately 2.1% of the company's stock are sold short. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include AT&T (T), General Electric (GE), Pfizer (PFE), IBM (IBM), Exxon Mobil (XOM), Bank of America (bac), Verizon Communications (VZ), Intel (INTC), Walt Disney (DIS) and Gilead Sciences (GILD).

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

Who are Metlife's major shareholders?

Metlife's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.11%), FMR LLC (3.80%), Diamond Hill Capital Management Inc. (1.06%), Bank of New York Mellon Corp (1.03%), AQR Capital Management LLC (0.96%) and Franklin Resources Inc. (0.72%). Company insiders that own Metlife stock include Carlos M Gutierrez, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Franklin Resources Inc., Bank of New York Mellon Corp, Snow Capital Management LP, Alberta Investment Management Corp, Caisse DE Depot ET Placement DU Quebec, TD Asset Management Inc. and Los Angeles Capital Management & Equity Research Inc.. View Insider Buying and Selling for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was acquired by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Panagora Asset Management Inc., Acadian Asset Management LLC, AJO LP, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Assetmark Inc., FMR LLC and MUFG Securities EMEA plc. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $51.97.

How big of a company is Metlife?

Metlife has a market capitalization of $47.79 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. Metlife employs 48,000 workers across the globe.View Additional Information About Metlife.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com/.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  822 (Vote Outperform)
Underperform Votes:  565 (Vote Underperform)
Total Votes:  1,387
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Featured Article: Stock Symbol

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel